X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Merck & Co., which has been seeking U.S. approval for a successor to its withdrawn arthritis painkiller Vioxx for nearly three years, says it has given regulators new patient data about the drug and expects a decision by April.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.